(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZIVACOL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ZIVACOL

ST13

US500000079438085

Class

5

Filing

79438085

Registration

8268681

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

06/25/2026

Trademark type

Word

Nice classes

5

Filing date

10/23/2025

Registration date

05/26/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/26/2026

Last transaction

06/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

EVANKO, PATRICIA MALESARDI

Law office

N10

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Tillotts Pharma AG

Representatives

No representative data.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary preparationsfor diagnosisprevention and treatment of gastrointestinal diseases and disorderspharmaceutical products for treatment of inflammation; dietetic food and beverages for medical usefor diagnosisprevention and treatment of gastrointestinal disorders

Publications

History of USPTO decisions and trademark events.

13 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/25/2026

GPNX

NOTIFICATION PROCESSED BY IB

06/18/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/26/2026

PUBO

PUBLISHED FOR OPPOSITION

04/07/2026

NPUB

NOTICE OF PUBLICATION

04/01/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/18/2026

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/18/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/10/2026

DOCK

ASSIGNED TO EXAMINER

03/10/2026

MAFR

APPLICATION FILING RECEIPT MAILED

12/16/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/16/2025

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

12/15/2025

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

11/27/2025

Continuous trademark protection

Get notified about every new filing that threatens ZIVACOL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.